working

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Terminating coverage

Companies: PLEDPHARMA (PLED:STO)Egetis Therapeutics AB (EGTX:OME)

Q2 report: EMA filing on October 9

Companies: Egetis Therapeutics AB

Progress for the ReTRIACt trial, not much left

Companies: PLEDPHARMA (PLED:STO)Egetis Therapeutics AB (EGTX:OME)

Egetis files MAA in Europe

Companies: Egetis Therapeutics AB

ReTRIACt struggle continues

Companies: PLEDPHARMA (PLED:STO)Egetis Therapeutics AB (EGTX:OME)

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top